{"title":"Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors","description":"","products":[{"product_id":"axitinib-5-mg","title":"Axitinib 5mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eAxitinib is used for kidney cancer called renal cell carcinoma that is advanced, often after an earlier treatment has stopped working.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt can also be used with immunotherapy as a first treatment for advanced renal cell carcinoma in some treatment plans.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 2mg to 10mg twice daily; the usual starting dose is 5mg twice daily, with increases or reductions based on tolerance and blood pressure.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547336458609,"sku":"52014","price":13.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_e5534cb2-a3c2-4bad-8dfc-c8dd4a6a3ba7.png?v=1786417947"},{"product_id":"tivozanib-0-89-mg","title":"Tivozanib 0.89mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eTivozanib is used for relapsed or refractory advanced renal cell carcinoma after two or more earlier systemic treatments.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 0.89mg to 1.34mg once daily for 21 days followed by 7 days off; the usual starting dose is 1.34mg once daily on that schedule.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547340587377,"sku":"52154","price":153.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_35d1aba0-54c0-40f6-b52d-f4fe32f33b6b.png?v=1786432426"},{"product_id":"tivozanib-1-34-mg","title":"Tivozanib 1.34mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eTivozanib is used for relapsed or refractory advanced renal cell carcinoma after two or more earlier systemic treatments.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 0.89mg to 1.34 mg once daily for 21 days followed by 7 days off; the usual starting dose is 1.34mg once daily on that schedule.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547340620145,"sku":"52155","price":154.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_a9a47d1d-0184-46db-b8fe-76bbafde6f2e.png?v=1786432455"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/collections\/Multiple_Blue_Caps.jpg?v=1777780298","url":"https:\/\/find-a-drug.com\/collections\/vascular-endothelial-growth-factor-receptor-vegfr-tyrosine-kinase-inhibitors.oembed","provider":"Find-A-Drug","version":"1.0","type":"link"}